Samsung nets FDA clearance for new DR algorithm

2018 09 25 18 48 0519 Samsung Rsna 2017 400

Samsung has received U.S. Food and Drug Administration (FDA) 510(k) clearance for version 3.02 of its S-Vue digital radiography (DR) image postprocessing engine, which is designed to significantly lower radiation dose for pediatric patients.

After comparing S-Vue 3.02 with the firm's previous postprocessing engine on phantoms and in clinical studies, Samsung said that DR systems using S-Vue were able to lower dose by up to 45% for pediatric abdomen exams, by 15.5% for pediatric chest studies, and by up to 27% for pediatric skull exams.

S-Vue 3.02 is available on Samsung's GC85A and GM85 DR systems.

Page 1 of 376
Next Page